Study Shows No Clinical Benefit Observed With Atezolizumab as Adjunctive Therapy for Triple Negative Breast Cancer
Associations Between PEGS, Cardiometabolic Factors, and Demographics in US Adults
Physical Activity and Lupus Symptoms